GENE ONLINE|News &
Opinion
Blog

Alzheimer's Disease
R&D Alzheimer's Disease
New Study Reveals Fungal Link to Alzheimer’s Disease Development
2023-10-26
Alzheimer's Disease
Intermittent Fasting Improves Alzheimer’s Pathology, Possibly Breaks New Ground for Future Research
2023-08-24
R&D DementiaAlzheimer's Disease
Scientists Have Identified 32 Proteins Associated with Dementia Risk: A Promising Step Towards Early Detection and Potential Treatments
2023-08-02
Trials & Approvals Alzheimer's DrugFDA Approval
FDA Granted Eisai and Biogen’s New Alzheimer’s Drug a Traditional Approval, Making Medicare Coverage Possible
2023-07-11
Editors' Picks Singapore
GeneOnline’s Weekly News Highlights: July 3-7
2023-07-10
R&D Alzheimer's DiseaseGut Microbiota
Gut Microbiome Composition Offers Insights for Diagnosis and Intervention of Early Alzheimer’s Disease
2023-06-28
R&D MemoryAlzheimer's Disease
Latest Study on Neuronal Gene Expression May Shed Light on the Memory Formation Process
2023-03-30
Trials & Approvals Alzheimer's Disease
Eisai and Biogen’s Alzheimer’s Med, Leqembi, Granted FDA Approval
2023-01-09
Trials & Approvals Eisai
Eisai Unveils Lecanemab Data Following Reports of Second Alzheimer’s Patient Death
2022-11-30
Trials & Approvals Alzheimer's Disease
Axsome’s AXS-05 Achieves Endpoints In Alzheimer’s Agitation Trial
2022-11-29
Trials & Approvals Alzheimer's Disease
Roche’s Gantenerumab Fails Trials In Alzheimer’s Disease
2022-11-15
Trials & Approvals Alzheimer's Disease
Though Alzheimer’s Treatment Fails Presenting Primary Endpoints, TauRx is Still Seeking Approval
2022-10-06
Trials & Approvals Biogen
Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial
2022-09-28
Deals Alzheimer's Disease
Merck Dangles $1.1 Billion For Cerevance To Discover New Targets For Alzheimer’s
2022-08-10
Special Alzheimer's Disease
Billions of Research Dollars May Have Been Wasted Due to Fraudulent Alzheimer’s Study
2022-07-26
1 2 3 4 … 6
LATEST
Exosomes: What They Do and Who’s Doing What
2025-04-21
Eli Lilly’s Orforglipron Shows Phase 3 Success: First Oral GLP-1 Drug for Type 2 Diabetes and Weight Loss
2025-04-21
Dupixent Makes History with FDA Approval as First New CSU Treatment in Over a Decade
2025-04-20
Multiple PCV Doses May Be Needed for Immunocompromised Type 2 Diabetics to Maintain Protection, Study Finds
2025-04-19
Multiple PCV Doses May Be Needed for Immunocompromised Individuals with Type 2 Diabetes
2025-04-19
Dr. Lauren Krupp, FAAN, Advocates Early Intervention and Family Support in Pediatric MS Treatment.
2025-04-19
Dr. Lauren B. Krupp Recommends Early, Aggressive Treatment with High-Efficacy Therapies for Pediatric Multiple Sclerosis
2025-04-19
READ MORE
EVENT
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-21
World Vaccine Congress Washington 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-04-26
SABPA OC/LA 17th Annual Biomedical Forum
Irvine, California, United States
2025-05-03
29th Taiwan Joint Cancer Conference 2025
Taipei, Taiwan
2025-05-05
Swiss Biotech Day 2025
Basel, Switzerland
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2025 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top